NO318352B1 - Triazolderivater med antifungal aktivitet, farmasoytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene ved fremstilling av medikamenter - Google Patents

Triazolderivater med antifungal aktivitet, farmasoytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene ved fremstilling av medikamenter Download PDF

Info

Publication number
NO318352B1
NO318352B1 NO20004511A NO20004511A NO318352B1 NO 318352 B1 NO318352 B1 NO 318352B1 NO 20004511 A NO20004511 A NO 20004511A NO 20004511 A NO20004511 A NO 20004511A NO 318352 B1 NO318352 B1 NO 318352B1
Authority
NO
Norway
Prior art keywords
doublet
compound
formula
doublets
group
Prior art date
Application number
NO20004511A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004511D0 (no
NO20004511L (no
Inventor
Sadao Oida
Satoshi Ohya
Toshiyuki Konosu
Makoto Mori
Takuya Uchida
Akihiko Nakagawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20004511D0 publication Critical patent/NO20004511D0/no
Publication of NO20004511L publication Critical patent/NO20004511L/no
Publication of NO318352B1 publication Critical patent/NO318352B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20004511A 1999-09-09 2000-09-08 Triazolderivater med antifungal aktivitet, farmasoytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene ved fremstilling av medikamenter NO318352B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25570299 1999-09-09
JP2000103826 2000-04-05

Publications (3)

Publication Number Publication Date
NO20004511D0 NO20004511D0 (no) 2000-09-08
NO20004511L NO20004511L (no) 2001-03-12
NO318352B1 true NO318352B1 (no) 2005-03-07

Family

ID=26542380

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004511A NO318352B1 (no) 1999-09-09 2000-09-08 Triazolderivater med antifungal aktivitet, farmasoytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene ved fremstilling av medikamenter

Country Status (23)

Country Link
US (3) US6391903B1 (fr)
EP (1) EP1083175B1 (fr)
KR (1) KR100592201B1 (fr)
CN (1) CN1167700C (fr)
AR (1) AR025610A1 (fr)
AT (1) ATE244238T1 (fr)
AU (1) AU778073B2 (fr)
BR (1) BR0004066A (fr)
CA (1) CA2317691C (fr)
DE (1) DE60003618T2 (fr)
DK (1) DK1083175T3 (fr)
ES (1) ES2200786T3 (fr)
HK (1) HK1034259A1 (fr)
HU (1) HU224699B1 (fr)
ID (1) ID27234A (fr)
IL (1) IL138329A0 (fr)
NO (1) NO318352B1 (fr)
NZ (1) NZ506818A (fr)
PT (1) PT1083175E (fr)
RU (1) RU2203280C2 (fr)
SA (1) SA00210602B1 (fr)
TR (1) TR200002610A2 (fr)
TW (1) TW530057B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI334866B (en) 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
EP1632228A4 (fr) * 2003-06-06 2006-11-29 Sankyo Co Composition medicinale contenant un compose triazole
CN101321522B (zh) * 2005-12-01 2012-05-30 巴斯利尔药物股份公司 环氧丁醇中间体的制备方法
US7790887B2 (en) 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322983D0 (en) * 1983-08-26 1983-09-28 Pfizer Ltd Triazole antifungal agents
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
IE912990A1 (en) * 1990-08-26 1992-03-11 Sankyo Co Anti-fungal triazole derivatives, their preparation and¹uses
JP2902345B2 (ja) 1995-04-06 1999-06-07 三共株式会社 トリアゾール抗真菌剤
EP0841327B1 (fr) 1995-04-06 2001-10-04 Sankyo Company Limited Agent antifongique de triazole
ES2159676T3 (es) * 1995-12-22 2001-10-16 Ss Pharmaceutical Co Derivados de triazol con actividad antimicotica e intermediarios.
JP3622882B2 (ja) 1996-10-04 2005-02-23 三共株式会社 トリアゾール誘導体を含有する医薬
AU5779598A (en) 1997-02-04 1998-08-25 Sankyo Company Limited Triazole derivatives
DE69829563T2 (de) 1997-07-08 2006-04-27 Kaneka Corp. Hydrosilylierungsverfahren und durch das verfahren hergestellte polymere
JPH1180135A (ja) 1997-07-08 1999-03-26 Sankyo Co Ltd 抗真菌トリアゾール化合物
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds

Also Published As

Publication number Publication date
US6337403B1 (en) 2002-01-08
US6391903B1 (en) 2002-05-21
HU224699B1 (en) 2006-01-30
TR200002610A3 (tr) 2001-06-21
KR100592201B1 (ko) 2006-06-23
RU2203280C2 (ru) 2003-04-27
AR025610A1 (es) 2002-12-04
HK1034259A1 (en) 2001-10-19
NO20004511D0 (no) 2000-09-08
EP1083175A2 (fr) 2001-03-14
HU0003555D0 (en) 2000-09-08
NO20004511L (no) 2001-03-12
CA2317691C (fr) 2009-02-17
DK1083175T3 (da) 2003-10-06
CA2317691A1 (fr) 2001-03-09
SA00210602B1 (ar) 2006-06-04
DE60003618T2 (de) 2004-04-15
ID27234A (id) 2001-03-15
HUP0003555A2 (hu) 2002-05-29
BR0004066A (pt) 2001-04-17
AU5657500A (en) 2001-03-15
CN1291610A (zh) 2001-04-18
EP1083175B1 (fr) 2003-07-02
NZ506818A (en) 2001-07-27
CN1167700C (zh) 2004-09-22
PT1083175E (pt) 2003-09-30
IL138329A0 (en) 2001-10-31
TR200002610A2 (tr) 2001-06-21
DE60003618D1 (de) 2003-08-07
AU778073B2 (en) 2004-11-11
ATE244238T1 (de) 2003-07-15
ES2200786T3 (es) 2004-03-16
US6392082B1 (en) 2002-05-21
EP1083175A3 (fr) 2001-04-11
TW530057B (en) 2003-05-01
KR20010067169A (ko) 2001-07-12

Similar Documents

Publication Publication Date Title
RU2036194C1 (ru) Способ получения производных триазола
US5620994A (en) Azolylamine derivative
EP0973768B1 (fr) Composes de type azole, leur production et leur utilisation
JP3808706B2 (ja) レニンインヒビター
JP2997947B2 (ja) トリアゾール化合物およびその用途
Kitazaki et al. Optically Active Antifungal Azoles. VI. Synthesis and Antifungal Activity of N-[(1R, 2R)-2-(2, 4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-N'-(4-substituted phenyl)-3 (2H, 4H)-1, 2, 4-triazolones and 5 (1H, 4H)-tetrazolones
EP1654254A1 (fr) Derives azole antifongiques contenant un groupe fonctionnel fluorovinyle et procede de preparation associe
Konosu et al. Triazole antifungals. II.: synthesis and antifungal activities of 3-acyl-4-methyloxazolidine derivatives
Ichikawa et al. Optically active antifungal azoles. XIII. Synthesis of stereoisomers and metabolites of 1-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone (TAK-456)
Ichikawa et al. Optically active antifungal azoles. XII. Synthesis and antifungal activity of the water-soluble prodrugs of 1-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone
NO318352B1 (no) Triazolderivater med antifungal aktivitet, farmasoytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene ved fremstilling av medikamenter
EP1144406B1 (fr) Derives d'azole antifongiques comprenant un groupe vinyle fluore et procede de preparation associe
JP3240129B1 (ja) トリアゾール抗真菌剤
JP3473952B2 (ja) トリアゾール抗真菌剤
HU191388B (en) Process for preparing new derivatives of aralkyl-triazoles and pharmaceutical compositions containing such compounds
WO1999002524A1 (fr) Composes antifongiques a base de triazole
JP3056412B2 (ja) アゾール化合物およびその用途
JP3989703B2 (ja) トリアゾール抗真菌剤
CZ297383B6 (cs) Deriváty triazolu s protiplísnovými úcinky
MXPA00008853A (en) Triazole derivatives having antifungal activity
Baji et al. Synthesis, antifungal activity and structure-activity relationships of 2-(alkyl or aryl)-2-(alkyl or polyazol-1-ylmethyl)-4-(polyazol-1-ylmethyl)-1, 3-dioxolanes
JPH08104676A (ja) アゾール化合物、その製造方法及び用途

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees